Cargando…

Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer

Immunotherapy that block PD-1–PD-L1 pathway can induce durable tumor control and result in the long-term survival of patients with advanced bladder cancers. However, these responses only occur in a subset of patients. We study gene expression profiles in 1763 muscle-invasive bladder cancers (MIBCs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Lin, Xu, Bin, Liu, Yushan, Wang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143239/ https://www.ncbi.nlm.nih.gov/pubmed/34104539 http://dx.doi.org/10.1080/2162402X.2021.1915574

Ejemplares similares

Tertiary Lymphoid Structures as Mediators of Immunotherapy Response
por: Vaghjiani, Raj G., et al.
Publicado: (2022)

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
por: Shang, Taiyu, et al.
Publicado: (2023)

Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies
por: N, Jacquelot, et al.
Publicado: (2021)

Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies
por: Trüb, Marta, et al.
Publicado: (2021)

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
por: Hou, Yue, et al.
Publicado: (2023)

Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy
por: Zou, Xinlei, et al.
Publicado: (2023)

Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma
por: Liu, Zhonglong, et al.
Publicado: (2022)

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer
por: Bertucci, François, et al.
Publicado: (2023)

Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy
por: Yin, Xuewen, et al.
Publicado: (2023)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
por: Lauss, Martin, et al.
Publicado: (2022)

Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
por: Koti, Madhuri, et al.
Publicado: (2017)

Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
por: Koti, Madhuri, et al.
Publicado: (2018)

CD20(+)CD22(+)ADAM28(+) B Cells in Tertiary Lymphoid Structures Promote Immunotherapy Response
por: Wu, Zhenghao, et al.
Publicado: (2022)

Perioperative immunotherapy for muscle-invasive bladder cancer
por: Kim, In-Ho, et al.
Publicado: (2020)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
por: Peyrottes, Arthur, et al.
Publicado: (2021)

Perioperative immunotherapy in muscle-invasive bladder cancer
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients With Lung Adenocarcinoma
por: Feng, Hong, et al.
Publicado: (2021)

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy
por: Garaud, Soizic, et al.
Publicado: (2022)

LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma
por: Liang, Haifeng, et al.
Publicado: (2023)

Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy
por: Lin, Liangbin, et al.
Publicado: (2019)

Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy
por: Aoyama, Shota, et al.
Publicado: (2021)

Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer
por: Zhong, Wenlong, et al.
Publicado: (2020)

Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
por: Pagliarulo, Fabio, et al.
Publicado: (2022)

Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer
por: Vaccaro, Alessandra, et al.
Publicado: (2023)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity
por: Silina, Karina, et al.
Publicado: (2019)

Tertiary lymphoid structure and B-cell-related pathways: A potential target in tumor immunotherapy
por: Qin, Meng, et al.
Publicado: (2021)

Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer
por: Qin, Meng, et al.
Publicado: (2021)

Tertiary lymphoid structures associate with improved survival in early oral tongue cancer
por: Almangush, Alhadi, et al.
Publicado: (2022)

Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response
por: Zhang, Qianqian, et al.
Publicado: (2023)

Erratum: Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
Publicado: (2022)

The High Level of Tertiary Lymphoid Structure Is Correlated With Superior Survival in Patients With Advanced Gastric Cancer
por: He, Wenting, et al.
Publicado: (2020)

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
por: Wu, Xiangkun, et al.
Publicado: (2020)

An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer
por: Zhang, Facai, et al.
Publicado: (2021)

YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer
por: Baek, Seung-Woo, et al.
Publicado: (2022)

Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer
por: An, Ye, et al.
Publicado: (2022)

Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment
por: Bejrananda, Tanan, et al.
Publicado: (2022)

Tertiary lymphoid structure and decreased CD8(+) T cell infiltration in minimally invasive adenocarcinoma
por: Wang, Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j8g5c6l9qfnmgl3btosknf5o7g